DRAPER, Utah, Dec. 03, 2024 (GLOBE NEWSWIRE) -- HealthEquity has announced its annual benefit trends webinar aimed at helping employers, HR professionals, and other business leaders prepare for the 2025 benefits landscape. The event will focus on benefits affordability for employers and employees, and how employers can address it.
The webinar is scheduled for Tuesday, December 10, at 2 p.m. (EST). The panel-style discussion will feature seasoned benefits experts from various industries. Attendees will hear actionable recommendations for employers looking to strengthen their benefits offerings and improve outcomes, all while navigating the complexities of today’s economic climate. This includes discussion on the following topics:
“2025 is likely to bring a great deal of change in terms of both cost and policy, and it’s important to understand the landscape and have a plan to support workers,” said HealthEquity Founder and Vice Chairman Dr. Steve Neeleman. “We want to equip employers and others to be part of the conversation and educate themselves for the year ahead.”
Attendees will hear from panelists, including:
Registration Details:
Participants can register for the webinar by clicking here.
About HealthEquity
HealthEquity and its subsidiaries administer HSAs and various other consumer-directed benefits for over 16 million accounts, working in close partnership with employers, benefits advisors, and health and retirement plan providers who share our unwavering commitment to our mission of saving and improving lives by empowering healthcare consumers. Through cutting-edge solutions, innovation, and a relentless focus on improving health outcomes, we empower individuals to take control of their healthcare journey while ultimately enhancing their overall well-being. Learn more about our “Purple service” and approach at www.healthequity.com.
References:
1 PwC. (2024). Healthcare Consumer Insights and Engagement Survey. PricewaterhouseCoopers LLP. Retrieved from https://www.pwc.com/us/en/industries/health-industries/library/healthcare-consumer-insights-survey.html
2 PwC. (2024). PwC 2025 Medical Cost Trend Report reveals rising healthcare costs. PricewaterhouseCoopers LLP. Retrieved from https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast/pwc-2025-medical-cost-trend-report-reveals-rising-healthcare-costs.html
Media Contact:
Amy Cerny
Director of Corporate Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$94.76 |
Daily Change: | 3.22 3.52 |
Daily Volume: | 1,041,470 |
Market Cap: | US$8.210B |
November 12, 2024 October 15, 2024 September 03, 2024 September 03, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB